id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
fnp-6285	French Society of Neuropathology, The	66th Meeting of the French Society of Neuropathology - Meeting Abstracts , December 6th. 2024	2025		.htm	application/xhtml+xml	3682	110	22	Free Neuropathol 6:2:11–12 Deciphering genetic and epigenetic of high grade gliomas with BRAF activating alteration is supporting the discovery of a new intracranial MPNST BRAF positive tumor type Benoît Lhermitte1,2*, Thibaut Wolf1,2*, Marlene Deschuyter2, Damien Reita2,4, Chinar Salmanli2, Agathe Chammas5, Marie-Pierre Chenard1,3, Guillaume Gauchotte6, Stephanie Lacomme7, Julien Todeschi8, Andres Coca8, Fabien Rech9, Romain Appay10, Roland Schott11, Georges Noel12, Sophie Martin2, Natacha Entz-Werlé2,13 Department of Pathology, University Hospitals of Strasbourg, Avenue Molière, 67098 Strasbourg Cedex, France UMR CNRS 7021, Laboratory Bioimaging and Pathologies, Team OnKO-3T – Translational, transversal and therapeutic oncology, University of Strasbourg University, Faculty of Pharmacy, 74 route du Rhin, 67405, Illkirch, France Centre de Ressources Biologiques, University Hospitals of Strasbourg, Avenue Molière, 67098 Strasbourg Cedex, France Department of Cancer Molecular Genetics Laboratory of Biochemistry and Molecular Biology, University Hospitals of Strasbourg, France Department of Pediatric Radiology, University Hospitals of Strasbourg, Avenue Molière, 67098 Strasbourg Cedex, France Department of Biopathology, CHRU Nancy, Université de Lorraine, INSERM U1256, NGERE, F-54500 Vandoeuvre-lès-Nancy, France Centre de Ressources Biologiques, BB-0033-00035, CHRU Nancy, F-54500 Vandoeuvre-lès-Nancy, France Neurosurgery Department, University Hospital of Strasbourg, 67098 Strasbourg, France Department of Neurosurgery, CHRU-Nancy, Université de Lorraine, Nancy, France Department of Pathology and Neuropathology, University Hospital of Timone Marseille, 264 rue Saint-Pierre, 13005, Marseille, France Oncology Department, ICANS (Institut de Cancérologie Strasbourg Europe), 17 rue Albert Calmette, 67200, Strasbourg, France Radiotherapy Department, ICANS (Institut de Cancérologie Strasbourg Europe), 17 rue Albert Calmette, 67200, Strasbourg, France Pediatric Onco-hematology unit, University Hospitals of Strasbourg, Avenue Molière, 67098 Strasbourg Cedex, France * Thibaut Wolf1, Damien Reita2,3, Marlène Deschuyter3, Julie Buffa2, Erwan Pencreach2, Eric Jeandidier4, Marie-Pierre Chenard1, Natacha Entz-Werlé3–5,Benoît Lhermitte1,3 Pathology Department, University Hospital of Strasbourg, 67098 Strasbourg, France Oncobiology Platform, Laboratory of Biochemistry, University Hospital of Strasbourg, 67098 Strasbourg, France UMR CNRS 7021, Laboratory Bioimaging and Pathologies, OnKO3T team, Faculty of Pharmacy, 67401 Illkirch, France Cytogenetic Departement, Mulhouse Hospital, 68100 Mulhouse, France Pediatric Oncology Department, University Hospital of Strasbourg, 67098 Strasbourg, France Clarifying the diagnosis and prognosis of BRAF-mutant gliomas requires testing for CDKN2A homozygous deletion (HD).	cache/fnp-6285.htm	txt/fnp-6285.txt